89 related articles for article (PubMed ID: 6399530)
21. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.
Reaven GM
Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():5S-12S. PubMed ID: 8299489
[No Abstract] [Full Text] [Related]
22. [Obesity and diabetes mellitus].
Ditschuneit H; Faulhaber JD
Arztl Forsch; 1970 Nov; 24(11):313-25. PubMed ID: 4922002
[No Abstract] [Full Text] [Related]
23. Metabolic consequences of weight loss on glucose metabolism and insulin action in type 2 diabetes.
Williams KV; Kelley DE
Diabetes Obes Metab; 2000 Jun; 2(3):121-9. PubMed ID: 11220547
[No Abstract] [Full Text] [Related]
24. [The fundamentals of the pharmacology of antidiabetic substances].
Losert W
Pharmazie; 1975 Jul; 30(7):422-33. PubMed ID: 1101277
[No Abstract] [Full Text] [Related]
25. [Role of insulin resistance in the pathogenesis of diabetes mellitus].
Reaven GM
Medicina (B Aires); 1978; 38(5):577-86. PubMed ID: 368502
[No Abstract] [Full Text] [Related]
26. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
Scheen AJ
Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
[No Abstract] [Full Text] [Related]
27. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
Yoshimoto K; Ozawa S; Ishida H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
[No Abstract] [Full Text] [Related]
28. Beta cells and glucose in diabetes.
Nutr Rev; 1973 Jan; 31(1):8-10. PubMed ID: 4571257
[No Abstract] [Full Text] [Related]
29. Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.
Evans AJ; Krentz AJ
Diabetes Obes Metab; 2001 Aug; 3(4):219-29. PubMed ID: 11520301
[No Abstract] [Full Text] [Related]
30. The insulin receptor: its role in insulin resistance of obesity and diabetes.
Olefsky JM
Diabetes; 1976 Dec; 25(12):1154-62. PubMed ID: 791735
[No Abstract] [Full Text] [Related]
31. [Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
Vague P; Vague J
Journ Annu Diabetol Hotel Dieu; 1972; 13(0):55-65. PubMed ID: 4605752
[No Abstract] [Full Text] [Related]
32. [Oxidative stress, insulin secretion, and insulin resistance].
Poitout V; Tanaka Y; Reach G; Robertson RP
Journ Annu Diabetol Hotel Dieu; 2001; ():75-86. PubMed ID: 11565471
[No Abstract] [Full Text] [Related]
33. Diabetes mellitus and insulin receptors.
Krans HM
Neth J Med; 1985; 28(2):59-62. PubMed ID: 3919324
[No Abstract] [Full Text] [Related]
34. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus.
Truglia JA; Livingston JN; Lockwood DH
Am J Med; 1985 Aug; 79(2B):13-22. PubMed ID: 3898828
[TBL] [Abstract][Full Text] [Related]
35. Insulin receptors and action in clinical disorders of carbohydrate tolerance.
Pollet RJ
Am J Med; 1983 Nov; 75(5B):15-22. PubMed ID: 6369964
[TBL] [Abstract][Full Text] [Related]
36. Insulin secretion in obesity: pseudodiabetes?
Karam JH; Grodsky GM; Forsham PH
Am J Clin Nutr; 1968 Dec; 21(12):1445-54. PubMed ID: 4881680
[No Abstract] [Full Text] [Related]
37. Pathophysiology of type 2 diabetes.
Scheen AJ
Acta Clin Belg; 2003; 58(6):335-41. PubMed ID: 15068125
[TBL] [Abstract][Full Text] [Related]
38. Glucose metabolism in obesity and type 2 diabetes.
Bonadonna RC; De Fronzo RA
Diabete Metab; 1991 May; 17(1 Pt 2):112-35. PubMed ID: 1936466
[TBL] [Abstract][Full Text] [Related]
39. [Is hyperfattyacidemia related to the occurrence of diabetes?].
Oikawa S
Nihon Rinsho; 2005 Feb; 63 Suppl 2():646-8. PubMed ID: 15779455
[No Abstract] [Full Text] [Related]
40. [Mitochondrial gene mutations in diabetes mellitus].
Hinokio Y; Oka Y
Nihon Rinsho; 2002 Oct; 60 Suppl 10():651-4. PubMed ID: 12430298
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
